The effect of repetitive transcranial magnetic stimulation on immediate and long-term cognitive functions in Alzheimer's dementia and mild cognitive impairment: a meta-analysis.
Bojun Wang, Ya Wang, Fenglei Yang and 4 others
PMID 41398677WHAT IT FOUND
Compared with sham, rTMS improved cognitive test scores right after treatment and at follow-up.
The follow-up estimate came from fewer studies, and effects varied widely across stimulation protocols.
Key findings
01Across 31 included RCTs, rTMS improved immediate general cognitive function versus sham (SMD = 0.930, 95% CI = 0.638 to 1.222), but heterogeneity was very high (I2 = 90.00%).
02In 9 long-term follow-up studies, rTMS also improved general cognitive function versus sham (SMD = 0.42, 95% CI = 0.13 to 0.70, I2 = 72.0%, p = 0.004).
03For immediate cognition, DLPFC stimulation showed a larger effect than other brain regions (SMD = 1.28 vs SMD = 0.52; between-subgroup p = 0.004), but parameter subgroup findings are not firm because protocols were heterogeneous.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Many included trials had intermediate or high risk of bias: 7 studies were high risk, 15 intermediate, and only 4 low risk. The pooled immediate effect was very inconsistent across studies (I2 90.00%), and the long-term effect was also inconsistent (I2 72.0%). Only 9 studies reported long-term follow-up, so the long-term estimate is based on a small set of trials. The long-term result may be affected by publication bias; the authors note the delayed cognitive efficacy results may have certain publication bias. Parameter subgroup findings are exploratory and confounded: the 80%MT subgroup also tended to have longer session duration and total treatment time, so the effect cannot be pinned to intensity alone. AD and MCI patients were analysed together even though they are different clinical stages and may respond differently. All included patients were over 60 years old, so the paper does not address younger MCI or AD populations. Outcomes were cognitive screening or dementia scale scores, not communication, daily functioning, safety, or long-term clinical benefit.
Declared interests
The paper names one funder: Key Project of Medical and health technology of Longgang District, Shenzhen.
The easy way to misread this
Do not read the subgroup results as a proven best rTMS protocol. The paper found larger immediate effects with DLPFC stimulation, lower intensity subgroups, total time over 800 min, and more than 20 sessions, but these were subgroup comparisons with high heterogeneity and confounded protocol combinations, and the authors say the parameter conclusions need caution.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →